Stay updated on Epacadostat & Nivolumab Combo in Immune Therapies Clinical Trial
Sign up to get notified when there's something new on the Epacadostat & Nivolumab Combo in Immune Therapies Clinical Trial page.

Latest updates to the Epacadostat & Nivolumab Combo in Immune Therapies Clinical Trial page
- Check5 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3. No visible changes to study details or page layout.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedAdded Revision: v3.4.2. Removed the lapse-in-government-funding notice and Revision: v3.4.1.SummaryDifference0.3%

- Check41 days agoChange DetectedNotice added about a lapse in government funding with information to check cc.nih.gov and opm.gov; page revision updated from v3.4.0 to v3.4.1.SummaryDifference0.3%

- Check48 days agoChange DetectedThe page now adds a 'Show glossary' option and updates footer metadata to include 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', along with a 'No FEAR Act Data' notice. These are non-critical UI and metadata updates that do not affect core study content.SummaryDifference0.2%

- Check84 days agoChange DetectedAdded a consolidated Locations section listing Alabama, California, North Carolina, and Tennessee. Removed the HHS Vulnerability Disclosure link and updated the page to revision v3.3.3.SummaryDifference0.4%

- Check105 days agoChange DetectedThe page now displays Revision: v3.3.2 and no longer shows Revision: v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Epacadostat & Nivolumab Combo in Immune Therapies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Epacadostat & Nivolumab Combo in Immune Therapies Clinical Trial page.